OncoTherapy Science Inc logo

4564 - OncoTherapy Science Inc Share Price

¥134 10.0  8.1%

Last Trade - 05/06/20

Sector
Healthcare
Size
Small Cap
Market Cap £171.9m
Enterprise Value £137.6m
Revenue £2.30m
Position in Universe 1641st / 3870
Bullish
Bearish
Unlock 4564 Revenue
Momentum
Relative Strength (%)
1m
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High
50d MA
200d MA
Margin of Safety
Qualifying GuruScreens
Financial Summary
FINANCIAL BRIEF: : For the fiscal year ended 31 March 2020, OncoTherapy Science, Inc. revenues increased 13% to Y316.2M. Net loss applicable to common stockholders decreased 24% to Y2.24B. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Lower net loss reflects Impairment loss decrease of 48% to Y165.9M (expense), SP New Stock Subscription Right increase of 5% to Y87.4M (income).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

4564 Revenue Unlock 4564 Revenue

Net Income

4564 Net Income Unlock 4564 Revenue

Normalised EPS

4564 Normalised EPS Unlock 4564 Revenue

PE Ratio Range

4564 PE Ratio Range Unlock 4564 Revenue

Dividend Yield Range

4564 Dividend Yield Range Unlock 4564 Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2020
31st Dec 2021
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
4564 EPS Forecasts Unlock 4564 Revenue
Profile Summary

OncoTherapy Science, Inc. is a Japan-based company mainly engaged in the development of drugs. The Company is involved in the development of low molecular drugs, antibody drugs and other drugs, as well as the provision and clinical development of medical candidate substances. The Company operates its business in cooperation with universities and other corporations. The Company provides its licenses to pharmaceutical manufacturers. The Company also involves in T Cell Receptor(TCR) analysis business.

Directors
Last Annual March 31st, 2020
Last Interim March 31st, 2020
Incorporated April 6, 2001
Public Since December 8, 2003
No. of Shareholders: n/a
No. of Employees: 63
Sector Healthcare
Industry Biotechnology & Medical Research
Index
Exchange Tokyo Stock Exchange
Shares in Issue 176,332,000
Free Float (0.0%)
Eligible for
ISAs
SIPPs
4564 Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for 4564
Upcoming Events for 4564
Friday 19th June, 2020 Estimate
OncoTherapy Science Inc Annual Shareholders Meeting
Frequently Asked Questions for OncoTherapy Science Inc
What is the OncoTherapy Science Inc share price?

As of 05/06/20, shares in OncoTherapy Science Inc are trading at ¥134, giving the company a market capitalisation of £171.9m. This share price information is delayed by 15 minutes.

How has the OncoTherapy Science Inc share price performed this year?

Shares in OncoTherapy Science Inc are currently trading at ¥134 and the price has moved by 25.23% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the OncoTherapy Science Inc price has moved by 13.79% over the past year.

What are the analyst and broker recommendations for OncoTherapy Science Inc?

Of the analysts with advisory recommendations for OncoTherapy Science Inc, there are there are currently "buy" , "hold" and "sell" recommendations. The overall consensus recommendation for OncoTherapy Science Inc is Not available. You can view the full broker recommendation list by unlocking its StockReport.

When will OncoTherapy Science Inc next release its financial results?

OncoTherapy Science Inc is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-03-31
What is the OncoTherapy Science Inc dividend yield?

OncoTherapy Science Inc does not currently pay a dividend.

Does OncoTherapy Science Inc pay a dividend?

OncoTherapy Science Inc does not currently pay a dividend.

When does OncoTherapy Science Inc next pay dividends?

OncoTherapy Science Inc does not currently pay a dividend.

How do I buy OncoTherapy Science Inc shares?

To buy shares in OncoTherapy Science Inc you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of OncoTherapy Science Inc?

Shares in OncoTherapy Science Inc are currently trading at ¥134, giving the company a market capitalisation of £171.9m.

Where are OncoTherapy Science Inc shares listed? Where are OncoTherapy Science Inc shares listed?

Here are the trading details for OncoTherapy Science Inc:

Country of listing: Japan
Exchange: TYO
Ticker Symbol: 4564
What kind of share is OncoTherapy Science Inc?

Based on an overall assessment of its quality, value and momentum, OncoTherapy Science Inc is currently classified as a Momentum Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a OncoTherapy Science Inc share price forecast 2020?

We were not able to load any forecast data for OncoTherapy Science Inc.

How can I tell whether the OncoTherapy Science Inc share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like OncoTherapy Science Inc. Over the past six months, the relative strength of its shares against the market has been 52.58%. At the current price of ¥134, shares in OncoTherapy Science Inc are trading at 49.61% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the OncoTherapy Science Inc PE Ratio?

We were not able to find PE ratio data for OncoTherapy Science Inc.

Who are the key directors of OncoTherapy Science Inc?

OncoTherapy Science Inc's management team is headed by:

Kyoko Fujiya - PRE
Takuya Tsunoda - DRC
Suyoun Chung - OTH
Hiroshi Yamaji - DRC
Toyomasa Katagiri - IND
Who are the major shareholders of OncoTherapy Science Inc?

Here are the top five shareholders of OncoTherapy Science Inc based on the size of their shareholding:

Nakamura (Yusuke) Individual Investor
Percentage owned: 7.1% (12.5m shares)
SMBC Trust Bank (Trust) Corporation
Percentage owned: 4.14% (7.30m shares)
Shionogi & Co Ltd Corporation
Percentage owned: 4.14% (7.30m shares)
Nakatsuru (Shuichi) Individual Investor
Percentage owned: 3.32% (5.85m shares)
Furukawa (Yoichi) Individual Investor
Percentage owned: 2.97% (5.24m shares)
Similar to 4564
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.